M. Vu

发表

Striking Dichotomy of PD‐L1 and PD‐L2 Pathways in Regulating Alloreactive CD4+ and CD8+ T Cells In Vivo

X. Li, M. Sayegh, A. Habicht, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

CCL21 (SLC) improves tumor protection by a DNA vaccine in a Her2/neu mouse tumor model

B. Dörken, M. Vu, M. Lipp, 2011, Cancer Gene Therapy.

CCL19 as an adjuvant for intradermal gene gun immunization in a Her2/neu mouse tumor model: improved vaccine efficacy and a role for B cells as APC

B. Dörken, S. Norley, M. Vu, 2012, Cancer Gene Therapy.

The Common γc-Cytokines and Transplantation Tolerance

X. Li, M. Vu, M. D. Vu, 2004 .

Significant prolongation of renal allograft survival by delayed combination therapy of FK778 with tacrolimus in nonhuman primates1

I. Bekersky, M. Vu, Wenlei Jiang, 2003, Transplantation.

Synergistic effects of mycophenolate mofetil and sirolimus in prevention of acute heart, pancreas, and kidney allograft rejection and in reversal of ongoing heart allograft rejection in the rat.

Junzheng Peng, M. Vu, B. Leduc, 1998, Transplantation.

Critical, but Conditional, Role of OX40 in Memory T Cell-Mediated Rejection1

L. Turka, X. Li, M. Sayegh, 2006, The Journal of Immunology.

This information is current as Memory T Cell-Mediated Rejection Critical , but Conditional , Role of OX 40 in LiLaurence

L. Turka, X. Li, M. Sayegh, 2006 .

Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment.

C. Klein, D. Hose, F. Prósper, 2017, Cancer cell.

Target Expression , Genera tion , Preclinical Activity , and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM 801 for Multiple Myeloma Treatment Graphical

C. Klein, D. Hose, F. Prósper, 2022 .

Proteasomes Modulate Balance Among Proapoptotic and Antiapoptotic Bcl-2 Family Members and Compromise Functioning of the Electron Transport Chain in Leukemic Cells1

M. Vu, G. Chinnadurai, R. Bertrand, 2001, The Journal of Immunology.

Cellsthe Electron Transport Chain in Leukemic Members and Compromise Functioning of Proapoptotic and Antiapoptotic Bcl-2 Family Proteasomes Modulate Balance Among

M. Vu, G. Chinnadurai, R. Bertrand, 2001 .

Discovery of a series of novel 5H-pyrrolo[2,3-b]pyrazine-2-phenyl ethers, as potent JAK3 kinase inhibitors.

Johannes C. Hermann, A. Kuglstatter, M. Vu, 2013, Bioorganic & medicinal chemistry letters.

Synergistic effect of vincristine with tacrolimus or sirolimus in prevention of acute heart allograft rejection in the rat

M. Vu, Wenlei Jiang, S. Qi, 2003, Microsurgery.

Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey.

Junzheng Peng, I. Bekersky, M. Vu, 1998, Transplantation.

Different Costimulatory and Growth Factor Requirements for CD4+ and CD8+ T Cell-Mediated Rejection 1

X. Li, Yongsheng Li, M. Sayegh, 2004, The Journal of Immunology.

NK cells promote transplant tolerance by killing donor antigen-presenting cells

X. Li, Xuemin Xu, M. Vu, 2006, The Journal of experimental medicine.

Cell-Mediated Rejection T + and CD 8 + Requirements for CD 4 Different Costimulatory and Growth Factor

X. Li, Yongsheng Li, M. Sayegh, 2004 .

Mycophenolate mofetil is compatible with CD28/CD154 costimulatory blockade in preventing transplant rejection.

T. Strom, X. Li, Yongsheng Li, 2005, Transplantation.

Study of T-cell costimulatory blockade in vivo at a single-cell level.

X. Li, M. Vu, M. D. Vu, 2005, Methods in molecular medicine.

Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat.

S. Busque, M. Vu, L. Dumont, 1997, Transplantation.

HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model

B. Dörken, P. Schlag, W. Walther, 2012, Oncoimmunology.

TherapySubsets and Their Resistance to Depletion OX40 Controls Functionally Different T Cell

X. Li, A. Kroemer, M. Vu, 2007 .

Scaffold hopping towards potent and selective JAK3 inhibitors: discovery of novel C-5 substituted pyrrolopyrazines.

Johannes C. Hermann, A. Kuglstatter, A. Lovey, 2014, Bioorganic & medicinal chemistry letters.

Synergistic effects of mycophenolate mofetil and sirolimus in prevention of acute heart, pancreas, and kidney allograft rejection and in reversal of ongoing heart allograft rejection in the rat.

M. Vu, B. Leduc, J. Wu, 1998, Transplantation.

OX40 costimulation turns off Foxp3+ Tregs.

Wenda Gao, N. Killeen, X. Li, 2007, Blood.

Strategic use of conformational bias and structure based design to identify potent JAK3 inhibitors with improved selectivity against the JAK family and the kinome.

Johannes C. Hermann, John Menke, Sue Jin, 2013, Bioorganic & medicinal chemistry letters.

RN486, a Selective Bruton's Tyrosine Kinase Inhibitor, Abrogates Immune Hypersensitivity Responses and Arthritis in Rodents

Daigen Xu, J. Demartino, S. Narula, 2012, Journal of Pharmacology and Experimental Therapeutics.

3-Amido pyrrolopyrazine JAK kinase inhibitors: development of a JAK3 vs JAK1 selective inhibitor and evaluation in cellular and in vivo models.

Alam Jahangir, Johannes C. Hermann, Seth Harris, 2013, Journal of medicinal chemistry.

Target Expression, Preclinical Activity and Mechanism of Action of EM801: A Novel First-in-Class Bcma T-Cell Bispecific Antibody for the Treatment of Multiple Myeloma

D. Hose, F. Prósper, J. Miguel, 2015 .

OX40 Controls Functionally Different T Cell Subsets and Their Resistance to Depletion Therapy1

Wenda Gao, X. Li, A. Kroemer, 2007, The Journal of Immunology.

Depletion Therapy to T Cell Subsets and Their Resistance OX40 Controls Functionally Different

X. Li, A. Kroemer, T. Maki, 2010 .

JPET #187740 RN486 [6-Cyclopropyl-8-fluoro-2-(2-hydroxymethyl-3-{1-methyl-5-[5-(4-methyl- piperazin-1-yl)-pyridin-2-ylamino]-6-oxo-1,6-dihydro-pyridin-3-yl}-phenyl)-2H- isoquinolin-1-one], a Selective Bruton’s Tyrosine Kinase (Btk) Inhibitor, Abrogates Immune Hypersensitivity Responses and Arthritis

Daigen Xu, J. Demartino, S. Narula, 2011 .

Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice.

V. Kuchroo, Wenda Gao, T. Strom, 2008, The Journal of clinical investigation.

Compromised kidney graft rejection response in Vervet monkeys after withdrawal of immunosuppressants tacrolimus and sirolimus.

I. Bekersky, M. Vu, W. Fitzsimmons, 2000, Transplantation.